Valuation: BLIS Technologies Limited

Market Cap 33.26M 18.9M 16.9M 15.64M 14.16M 26.5M 1.8B 26.94M 188M 74.44M 941M 70.95M 69.43M 2.98B P/E 2027 *
18.6x
P/E 2028 * 13.9x
Enterprise Value 29.64M 16.84M 15.06M 13.94M 12.62M 23.61M 1.6B 24M 168M 66.33M 838M 63.22M 61.87M 2.65B EV / Sales 2027 *
1.8x
EV / Sales 2028 * 1.61x
Free-Float
55.8%
Yield 2027 *
-
Yield 2028 * -
Current month-7.14%
1 month-3.70%
3 months+52.94%
6 months+62.50%
Current year+52.94%
1 week 0.03
Extreme 0.026
0.03
1 month 0.03
Extreme 0.026
0.03
Current year 0.01
Extreme 0.014
0.03
1 year 0.01
Extreme 0.014
0.03
3 years 0.01
Extreme 0.011
0.03
5 years 0.01
Extreme 0.011
0.06
10 years 0.01
Extreme 0.011
0.1
Manager TitleAgeSince
Chief Executive Officer - 2024-01-14
Director of Finance/CFO - 2017-11-26
Chief Tech/Sci/R&D Officer - 2016-08-31
Director TitleAgeSince
Director/Board Member - 2018-07-26
Chairman 68 2025-10-15
Chairman - 2023-07-13
Date Insider Type Main position Quantity % Market Cap. Importance
12/28/20 Free

Chief Financial Officer

595,000 0.0537%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+62.50%+18.18% 18.97M
+0.45%+3.13%+54.96%+125.16% 1,135B
+0.94%+4.93%+39.86%+78.72% 635B
+0.39%+1.44%+25.77%+97.48% 505B
+1.43%+4.31%+46.20%+67.12% 378B
-3.21%-2.10%+60.72%+33.22% 358B
-0.41%+2.64%+22.48%+49.82% 295B
+0.23%+3.66%+2.57%+23.69% 266B
+1.22%+4.63%+52.40%+64.85% 237B
+1.70%+3.67%+31.21%+102.15% 193B
Average +0.24%+2.51%+39.87%+66.04% 400.37B
Weighted average by Cap. +0.42%+2.85%+41.40%+83.61%

Financials

2027 *2028 *
Net sales 16.5M 9.38M 8.39M 7.76M 7.02M 13.15M 892M 13.36M 93.36M 36.93M 467M 35.2M 34.44M 1.48B 18.81M 10.69M 9.56M 8.84M 8.01M 14.99M 1.02B 15.23M 106M 42.09M 532M 40.12M 39.26M 1.68B
Net income 1.79M 1.02M 909K 841K 761K 1.43M 96.71M 1.45M 10.12M 4M 50.58M 3.82M 3.73M 160M 2.4M 1.36M 1.22M 1.13M 1.02M 1.91M 130M 1.94M 13.56M 5.36M 67.79M 5.11M 5M 215M
Net Debt -3.62M -2.06M -1.84M -1.7M -1.54M -2.89M -196M -2.93M -20.5M -8.11M -102M -7.73M -7.56M -325M -2.9M -1.65M -1.47M -1.36M -1.23M -2.31M -157M -2.35M -16.39M -6.48M -81.91M -6.18M -6.05M -259M
Projected Income Statement - Annual - BLIS Technologies Limited
Logo BLIS Technologies Limited
Blis Technologies Limited is a New Zealand-based manufacturer of advanced probiotic strains. The Company’s principal activity is developing healthcare products based on strains of bacteria that produce bacteriocin activity for sale in New Zealand and overseas. It delivers probiotic solutions for specific health targets, including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. Its probiotic portfolio includes BLIS K12, BLIS M18 and BLIS Q24. It sells ingredients and finishes goods to manufacturers and wholesale customers. The BLIS K12 (Streptococcus salivarius K12) is a probiotic to support the mouth and throat. The BLIS M18 (Streptococcus salivarius M18) is a probiotic to support teeth and gum health. The BLIS Q24 balances and restores the skin microbiome, restoring its natural health, clarity, and radiance. The Company’s products are sold throughout New Zealand and in Australia, Asia, Europe, and the United States.
Employees
43
Date Price Change Volume
26-10-23 NZ$0.0260 0.00% 7,504
26-10-22 NZ$0.0260 -3.70% 16,062
26-10-21 NZ$0.0270 +3.85% 361,960
26-10-20 NZ$0.0260 0.00% 462,834

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BLIS Technologies Limited